Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

NHC

NHC President and COO Retires

National Healthcare Corporation (NYSE American: NHC) has announced the retirement of R. Michael Ussery as the company's President and Chief Operating Officer, effective December 31, 2025. Ussery, who has dedicated 45 years to the company, began his journey with NHC in 1980 and has held various operational and leadership roles throughout his tenure.

Under Ussery's leadership, NHC saw significant growth and change. NHC affiliates operate 80 skilled nursing facilities with 10,349 beds, 26 assisted living communities with 1,413 units, nine independent living communities with 777 units, three behavioral health hospitals, 34 homecare agencies, and 32 hospice agencies. Additionally, NHC provides Alzheimer's and memory care units, pharmacy services, a rehabilitation services company, and management and accounting services to third-party post-acute operators.

During Ussery's time as President and COO, NHC's focus on high-quality patient care remained unwavering. Steve Flatt, CEO of NHC, expressed gratitude for Ussery's contributions and emphasized his dedication to NHC's success and growth. NHC board chairman Robert Adams commended Ussery for his integrity, exceptional work ethic, and outstanding leadership throughout his career.

As Ussery steps down, NHC looks towards the future under new leadership, while continuing its mission of providing exceptional care. Ussery expressed immense pride in the accomplishments achieved with the NHC team and conveyed confidence in the company's future, stating that he looks forward to watching NHC continue to thrive.

The company's performance metrics and financials for the most recent period will be disclosed in the upcoming financial reports. Following these announcements, the company's shares moved 2.39%, and are now trading at a price of $125.20. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS